Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Cell cycle and apoptosis regulation by NFAT transcription factors: new roles for an old player.

Mognol GP, Carneiro FR, Robbs BK, Faget DV, Viola JP.

Cell Death Dis. 2016 Apr 21;7:e2199. doi: 10.1038/cddis.2016.97. Review.

2.

Alteration of Homeostasis in Pre-osteoclasts Induced by Aggregatibacter actinomycetemcomitans CDT.

Kawamoto D, Ando-Suguimoto ES, Bueno-Silva B, DiRienzo JM, Mayer MP.

Front Cell Infect Microbiol. 2016 Mar 31;6:33. doi: 10.3389/fcimb.2016.00033. eCollection 2016.

3.

MicroRNAs in Osteoclastogenesis and Function: Potential Therapeutic Targets for Osteoporosis.

Ji X, Chen X, Yu X.

Int J Mol Sci. 2016 Mar 9;17(3):349. doi: 10.3390/ijms17030349. Review.

4.

Sirtuin 3 (SIRT3) maintains bone homeostasis by regulating AMPK-PGC-1β axis in mice.

Huh JE, Shin JH, Jang ES, Park SJ, Park DR, Ko R, Seo DH, Kim HS, Lee SH, Choi Y, Kim HS, Lee SY.

Sci Rep. 2016 Mar 1;6:22511. doi: 10.1038/srep22511.

5.

Signaling Pathways in Osteoclast Differentiation.

Kim JH, Kim N.

Chonnam Med J. 2016 Jan;52(1):12-7. doi: 10.4068/cmj.2016.52.1.12. Epub 2016 Jan 19. Review.

6.

Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis.

Nakajima K, Kho DH, Yanagawa T, Harazono Y, Hogan V, Chen W, Ali-Fehmi R, Mehra R, Raz A.

Cancer Res. 2016 Mar 15;76(6):1391-402. doi: 10.1158/0008-5472.CAN-15-1793. Epub 2016 Feb 2.

PMID:
26837763
7.

Calycosin Suppresses RANKL-Mediated Osteoclastogenesis through Inhibition of MAPKs and NF-κB.

Quan GH, Wang H, Cao J, Zhang Y, Wu D, Peng Q, Liu N, Sun WC.

Int J Mol Sci. 2015 Dec 10;16(12):29496-507. doi: 10.3390/ijms161226179.

8.

The Elusive Antifibrotic Macrophage.

Adhyatmika A, Putri KS, Beljaars L, Melgert BN.

Front Med (Lausanne). 2015 Nov 13;2:81. doi: 10.3389/fmed.2015.00081. eCollection 2015. Review.

9.

Luman is involved in osteoclastogenesis through the regulation of DC-STAMP expression, stability and localization.

Kanemoto S, Kobayashi Y, Yamashita T, Miyamoto T, Cui M, Asada R, Cui X, Hino K, Kaneko M, Takai T, Matsuhisa K, Takahashi N, Imaizumi K.

J Cell Sci. 2015 Dec 1;128(23):4353-65. doi: 10.1242/jcs.176057. Epub 2015 Oct 26.

10.

The Inhibitory Effect of Alisol A 24-Acetate from Alisma canaliculatum on Osteoclastogenesis.

Kim KJ, Leutou AS, Yeon JT, Choi SW, Kim SH, Yee ST, Choi KH, Nam SJ, Son YJ.

Int J Endocrinol. 2015;2015:132436. doi: 10.1155/2015/132436. Epub 2015 Jul 27.

11.

Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells.

Florencio-Silva R, Sasso GR, Sasso-Cerri E, Simões MJ, Cerri PS.

Biomed Res Int. 2015;2015:421746. doi: 10.1155/2015/421746. Epub 2015 Jul 13. Review.

12.

Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo.

Chen S, Jin G, Huang KM, Ma JJ, Wang Q, Ma Y, Tang XZ, Zhou ZJ, Hu ZJ, Wang JY, Qin A, Fan SW.

Sci Rep. 2015 Aug 4;5:12853. doi: 10.1038/srep12853.

13.

Focus on the p38 MAPK signaling pathway in bone development and maintenance.

Thouverey C, Caverzasio J.

Bonekey Rep. 2015 Jun 10;4:711. doi: 10.1038/bonekey.2015.80. eCollection 2015. Review.

14.

Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss.

Crotti TN, Dharmapatni AA, Alias E, Haynes DR.

J Immunol Res. 2015;2015:281287. doi: 10.1155/2015/281287. Epub 2015 May 3. Review.

15.

Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis.

Ke K, Safder AM, Sul OJ, Suh JH, Joe Y, Chung HT, Choi HS.

PLoS One. 2015 May 18;10(5):e0124869. doi: 10.1371/journal.pone.0124869. eCollection 2015.

16.

Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.

Herbert BA, Valerio MS, Gaestel M, Kirkwood KL.

PLoS One. 2015 May 6;10(5):e0125387. doi: 10.1371/journal.pone.0125387. eCollection 2015.

17.

miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.

Zhao C, Sun W, Zhang P, Ling S, Li Y, Zhao D, Peng J, Wang A, Li Q, Song J, Wang C, Xu X, Xu Z, Zhong G, Han B, Chang YZ, Li Y.

RNA Biol. 2015;12(3):343-53. doi: 10.1080/15476286.2015.1017205.

18.

NF-κB-direct activation of microRNAs with repressive effects on monocyte-specific genes is critical for osteoclast differentiation.

de la Rica L, García-Gómez A, Comet NR, Rodríguez-Ubreva J, Ciudad L, Vento-Tormo R, Company C, Álvarez-Errico D, García M, Gómez-Vaquero C, Ballestar E.

Genome Biol. 2015 Jan 5;16:2. doi: 10.1186/s13059-014-0561-5.

19.

Angelica sinensis extract inhibits RANKL-mediated osteoclastogenesis by down-regulated the expression of NFATc1 in mouse bone marrow cells.

Kong L, Zhao Q, Wang X, Zhu J, Hao D, Yang C.

BMC Complement Altern Med. 2014 Dec 12;14:481. doi: 10.1186/1472-6882-14-481.

20.

Regulation of NFATc1 in Osteoclast Differentiation.

Kim JH, Kim N.

J Bone Metab. 2014 Nov;21(4):233-41. doi: 10.11005/jbm.2014.21.4.233. Epub 2014 Nov 30. Review.

Items per page

Supplemental Content

Write to the Help Desk